MétaCan
Menu
← Retour à la cohorte
Enregistrement W4405092600 · doi:10.1182/blood-2024-202435

Patient Decision Aid for Extended Duration Thromboprophylaxis for Major Abdominopelvic Cancer Surgery: A Usability Study

2024· article· en· W4405092600 sur OpenAlexaffabout
Abdelrahman Noureldin, Victoria Ivankovic, Mary Farnand, Celine Dainhi, Rebecca C. Auer, Sameer Apte, Lev Bubis, Pamela Hebbard, Justin Rivard, Megan Delisle, Marc Carrier

Notice bibliographique

RevueBlood · 2024
Typearticle
Langueen
DomaineMedicine
ThématiqueVenous Thromboembolism Diagnosis and Management
Établissements canadiensOttawa HospitalUniversity of ManitobaCancerCare ManitobaUniversity of Ottawa
Organismes subventionnairesnon disponible
Mots-clésMedicineUsabilitySurgeryCancerDuration (music)General surgeryInternal medicineComputer scienceHuman–computer interaction

Résumé

récupéré en direct d'OpenAlex

Background: Clinical guidelines recommend patients receive extended duration thromboprophylaxis for 30 days following major abdominopelvic cancer surgery. There is equipoise regarding this recommendation amongst providers and patients. We developed a risk-stratified patient decision aid (PtDA) for patients undergoing major abdominopelvic cancer surgery considering extended duration thromboprophylaxis. We previously demonstrated the PtDA was acceptable to patients and clinicians and enhanced decision-making quality. However, the PtDA made was difficult to use in the perioperative setting. The objective of this study was to evaluate and improve the usability of the PtDA in the perioperative setting. Methods: We used an iterative process guided by a user-centered design framework. Consecutive patients undergoing major abdominopelvic cancer surgery from two major cancer centers in Canada, The Ottawa Hospital Cancer Center (TOHCC) and CancerCare Manitoba (CCMB), were recruited. Healthcare professionals involved in discharging patients who completed the PtDA were also recruited. Recruitment rate was defined as the number of total patients approached divided by the total eligible patients who consented to be contacted. Eligible and consented patients were invited to complete the PtDA and the Post Study System Usability Questionnaire (PSSUQ), and to record their decision regarding extended duration thromboprophylaxis. Adherence rate was defined as the number of eligible patients thereafter who actually completed the PSSUQ. Usability was also assessed by healthcare professionals discharging patients using the Consolidated Framework for Implementation Research (CFIR) Barrier Buster Tool. Results: Across both sites patients were recruited from November 2023 until May 2024. 108 consecutive patients were approached with study details, 22 refused to be contacted and 7 were ineligible The recruitment rate was 73% (79/108). Of the eligible and consented patients, the adherence rate was 25% (20/79). Overall, 15 patients from TOHCC and 5 from CCMB used the PtDA to help their decision regarding extended duration thromboprophylaxis. Eight (40%) patients were males, and 12 (60%) were females. Out of the 20 patients who used the PtDA, 18 (90%) completed the PSSUQ and reported their decision regarding extended duration thromboprophylaxis: 13 (65%) patients made a decision using our PtDA compared to 5 (25%) who preferred not to decide. Among the 13 who made a decision, 7 (54%) decided not to take extended duration thromboprophylaxis and 6 (46%) decided to take extended duration thromboprophylaxis. Regarding usability, the overall median score was 2 (range 2 - 6) on the PSSUQ. The usefulness subdomain median score was 3 (range 2 - 7). The median quality of information subdomain score was 2 (1 - 7). The median quality of design score was 2 (1 - 7). A total of 15 healthcare professionals were involved in discharging patients who used the PtDA and completed the PSSUQ. All healthcare professionals were resident physicians. Eight (53%) were males and seven (47%) were females. All 15 (100%) completed the follow-up CFIR Tool. From the 12 factors evaluated in the CFIR Tool, healthcare professionals identified a median number of six (range 1-11) facilitators and a median number of one (range 0-8) barrier. The factor most commonly identified as a facilitator was that the use of the PtDA is aligned with the healthcare professional's value, and the factor most commonly identified as a barrier was the lack of access to data to track the changes in outcomes related to the PtDA. Conclusion: The PtDA was found to be usable by patients based on PSSUQ scores. Healthcare professionals reported more facilitators than barriers to using the PtDA in the perioperative setting. However, few patients eligible for the study completed the PtDA in both centers, which may suggest ongoing challenges with implementing PtDAs in the perioperative setting. Additional research is required to assess clinical outcomes associated with its use in routine practice for patients, and address implementation barriers for providers.

Récupéré en direct depuis OpenAlex et désinversé. Les résumés ne sont pas conservés dans cette base de données : les index inversés représentent 8,6 Go des 9,3 Go de texte de la base, et le serveur dispose de 13 Go libres.

Comment cette classification a été obtenuedéplier

Prédiction machine sur la base complète

Imitation des enseignants

Ni prévalence calibrée, ni vérité terrain. Validation humaine à venir. Le volet Gemma est une étiquette directe du modèle pour chaque travail de la base, lue sur la notice réduite au titre. Le volet Codex est un classifieur appris des 10 348 étiquettes directes de Codex et calibré sur les taux pondérés de l'échantillon; les champs sans appui suffisant ne portent aucun appel Codex. Le mode candidate est l'union des deux volets; le consensus est leur intersection. Ces sorties portent le statut machine_predicted_unvalidated et ne sont pas des étiquettes humaines.

score de la tête « metaresearch » (Codex)0,028
score de la tête « metaresearch » (Gemma)0,059
Version: metacan-v3-hybrid-931329e0061cStatut de validation: machine_predicted_unvalidated
Catégories candidatesaucune
Catégories consensuellesaucune
DomaineSignal candidat: aucune · Signal consensuel: aucune
Devis d'étudeSignal candidat: Observationnel · Signal consensuel: aucune
GenreSignal candidat: Empirique · Signal consensuel: Empirique
Score de désaccord entre enseignants0,028
Score d'incertitude au seuil0,149

Scores du classifieur distillé par catégorie (deux têtes)

CatégorieCodexGemma
Métarecherche0,0280,059
Méta-épidémiologie (sens strict)0,0010,000
Méta-épidémiologie (sens large)0,0010,001
Bibliométrie0,0010,001
Études des sciences et des technologies0,0010,001
Communication savante0,0020,002
Science ouverte0,0010,001
Intégrité de la recherche0,0010,001
Charge utile insuffisante (le modèle a refusé de juger)0,0010,000

Scores machine (provisoires)

Les deux têtes enseignantes du modèle étudiant, lues sur ce travail. Un score ordonne la base pour la relecture; il n'affirme jamais une catégorie, et le statut de validation accompagne chaque rangée tel quel.

Scores de référence d'un modèle non mature (critères de maturité non atteints, 7 itérations). Un score ordonne; il n'affirme jamais une catégorie.

Tête enseignante Opus0,023
Tête enseignante GPT0,314
Écart entre enseignants0,291 · la distance entre les deux têtes enseignantes sur ce seul travail
Statut de validationscore_only:v0-immature-baseline · tel quel depuis la passe de notation : score_only signifie que le nombre peut ordonner les travaux, et qu'aucune étiquette de catégorie n'en découle

Classification

machine, non validée

Prédiction automatique; un appel candidat d’une seule source (Gemma direct ou Codex distillé), pas un consensus.

Les modèles n’ont appliqué aucune catégorie : rien dans la taxonomie ne correspondait à ce travail.
Devis d'étudeObservationnel
Domainenon disponible
GenreEmpirique

Le détail, modèle par modèle et score par score, se trouve en fin de page sous « Comment cette classification a été obtenue ».

En bref

Citations0
Publié2024
Routes d'admission2
Résumé présentoui

Explorer davantage

Même revueBlood→Même sujetVenous Thromboembolism Diagnosis and Management→Travaux en français237 207→